Want to see AMWL full AI Analyst Report?
AMWL Stock Chart & Stats
$11.66
$0.25(2.31%)
At close: 4:00 PM EDT
$11.66
$0.25(2.31%)
Day’s Range― - ―
52-Week Range$3.71 - $14.19
Previous CloseN/A
Volume57.88K
Average Volume (3M)94.64K
Market Cap
$198.66M
Enterprise Value-$27.81M
Total Cash (Recent Filing)$195.95M
Total Debt (Recent Filing)$2.98M
Price to Earnings (P/E)―
Beta2.23
Next Earnings
Nov 10, 2026EPS Estimate
-0.78Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.77
Shares Outstanding15,361,463
10 Day Avg. Volume91,576
30 Day Avg. Volume94,635
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.33
Price to Sales (P/S)0.32
P/FCF Ratio-1.19
Enterprise Value/Market Cap-0.14
Enterprise Value/Revenue-0.13
Enterprise Value/Gross Profit-0.26
Enterprise Value/Ebitda0.63
Forecast
1Y Price Target
$12.80Price Target Upside9.78% Upside
Rating ConsensusHold
Number of Analyst Covering7
EPS Forecast (FY)-2.57
Revenue Forecast (FY)$203.15M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetAmwell’s substantial cash balance and zero debt provide financial flexibility while it executes its restructuring and growth plans. Low leverage reduces financing risk, preserves resources for product investment, and gives the company more time to pursue operating cash-flow breakeven.
Improving Operating EfficiencyMaterial expense reductions and a sharply smaller adjusted EBITDA loss indicate that transformation actions are improving operating leverage. If maintained, this efficiency can help Amwell approach positive EBITDA and cash flow even before revenue growth fully recovers.
Federal Health IT PositionThe DHA intent to award could deepen Amwell’s role in the Military Health System and strengthen its credibility as federal health IT infrastructure. A multi-year relationship may support customer validation and create a platform for additional government and commercial opportunities.
Bears Say
Persistent Revenue ContractionSharp declines in total and subscription revenue show that Amwell’s core enterprise platform business is still contracting. Continued churn and prior-year comparison effects can weaken operating leverage, reduce recurring revenue scale, and delay a durable return to growth.
Ongoing Cash ConsumptionNegative operating and free cash flow means Amwell remains dependent on its cash reserves while pursuing breakeven. Although cash usage improved from prior years, continued consumption could reduce strategic flexibility and make execution of the profitability plan more important.
DHA Contract Timing RiskThe DHA award is not yet fully realized, and delayed negotiations create uncertainty around the timing and scope of incremental revenue. If expansion or implementation moves into 2027, expected growth and operating leverage could arrive later than management anticipates.
American Well News
AMWL FAQ
What was American Well’s price range in the past 12 months?
American Well lowest stock price was $3.71 and its highest was $14.19 in the past 12 months.
What is American Well’s market cap?
American Well’s market cap is $198.66M.
When is American Well’s upcoming earnings report date?
American Well’s upcoming earnings report date is Nov 10, 2026 which is in 22 days.
How were American Well’s earnings last quarter?
American Well released its earnings results on Aug 04, 2026. The company reported -$0.59 earnings per share for the quarter, beating the consensus estimate of -$0.86 by $0.27.
Is American Well overvalued?
According to Wall Street analysts American Well’s price is currently Undervalued.
Does American Well pay dividends?
American Well does not currently pay dividends.
What is American Well’s EPS estimate?
American Well’s EPS estimate is -0.78.
How many shares outstanding does American Well have?
American Well has 15,361,463 shares outstanding.
What happened to American Well’s price movement after its last earnings report?
American Well reported an EPS of -$0.59 in its last earnings report, beating expectations of -$0.86. Following the earnings report the stock price went up 24.952%.
Which hedge fund is a major shareholder of American Well?
Currently, no hedge funds are holding shares in AMWL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
American Well Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$12.80 (9.78% Upside)
$12.80 (9.78% Upside)
Blogger Sentiment
Neutral
AMWL Sentiment 60%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 3.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $170.3K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
105.63%
12-Months-Change
Fundamentals
Return on Equity
-33.27%
Trailing 12-Months
Asset Growth
-15.82%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
American Well
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
AMWL Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
Mixed-but-cautiously-optimistic. The company shows meaningful operational progress: large cash reserves with no debt, substantial cost reductions, improved adjusted EBITDA (near breakeven), a healthier subscription mix (now >50% of revenue and up sequentially), and an independently validated clinical program. Strategic wins and credibility (DHA intent to award, Nature-published SilverCloud results) support upside. However, material year-over-year revenue and visit declines (total revenue −26.6%, subscription −36.5%, platform visits −28.4%) and timing uncertainty around DHA contract realization and near-term Q3 cost impacts keep the situation balanced. Management tightened guidance and raised full-year adjusted EBITDA expectations, but topline recovery in 2027 remains contingent on converting pipeline opportunities into signed contracts.View all AMWL earnings summariesAMWL Revenue Breakdown
46.12% Visits
43.37% Platform subscription
10.50% Other
AMWL Stock 12 Month Forecast
Average Price Target
$12.80
▲(9.78% Upside)
Technical Analysis
Ownership Overview
9.48% Insiders
10.53% Mutual Funds
17.02% Other Institutional Investors
57.95% Public Companies and
Individual Investors